Nyxoah SA
Healthcare / Medical Devices
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Performance
--
Today 0.00 (0.00%)
NYXH
Metrics
Market Cap159M
Latest Price$1.55
Previous Close$1.54
Volume370K
52 Week High$6.88
52 Week Low$1.26
52 Week Change-71.53%
Average Volume379K
Revenue22M
EPS-2.55
P/E Ratio0
Forward P/E-1.831
Price/Book1.616
Profit Margin0.00%
Operating Margin-2.68%
Return on Equity-1.23%
Dividend Yield0.00%